Abiopharma

🔍 MILLER MICHAEL PATRICK (Director)

Company: PUMA BIOTECHNOLOGY, INC. (PBYI)

Report Date: 2026-06-11

Detailed Transactions and Holdings:

• Acquired 27,000 shares of Common Stock (Direct)
  Date: 2026-06-11 | Code: A | equity_swap_involved: 0 | shares_owned_after: 81,000.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.